Humpath.com - Human pathology

Home > A. Molecular pathology > STRN3

STRN3

Monday 7 January 2019

WKP

Pathology

- NTRK3 fusion genes in fibrosarcomas (30520818)

  • NTRK fusions in malignant tumors are therapeutic targets of tyrosine kinase inhibitors.
  • CD34-positive fibrosarcoma of bone and soft tissue could be a good candidate for NTRK testing.
  • STRN1-NTRK3 and STRN3-NTRK fusion genes